Evaluation of effectiveness in patients with schizophrenia who are switched from prior antipsychotics to aripiprazole

Not Applicable

• Conditions: schizophrenia

• Registration Number: JPRN-UMIN000005587
• Lead Sponsor: Department of Psychiatry, Graduate School of Medicine, Kyoto University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-01
• Study Completion: 2014-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

-articipants under the comatose state -participants under the strong influence of central nervous system depressant -participants in administration of epinephrine -participants who have a histry of allergy for aripiprazole -participants who are contacting diabetes mellitus, or have a medical history of diabetes mellitus -participants who are during pregnancy or possibility of pregnancy -the attending doctor appraise participants for inadequate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Brief Psychiatric Rating Scale: BPRS, Clinical global impression : CGI-S and I, Drug-Induced Extrapyramidal Symptoms Scale: DIEPSS Japanese Version for the Schizophrenia Quality of Life Scale: JSQLS

Secondary Outcome Measures

Name	Time	Method
Drug Attitude Inventory:DAI-10 Preference of medicine Questionnaire:POM Body Weight,Body Mass Index,Blood Glucose,Prolactin